July 29, 2016
SUNNYVALE, Calif., /PRNewswire/ — VytronUS, Inc. (“VytronUS”), a privately held medical device company developing novel technologies for the treatment of cardiac arrhythmias, announced today that it has secured $49 million in Series C … Continued
July 26, 2016
Optune designated as category 2A treatment for newly diagnosed GBM, indicating uniform consensus that the intervention is appropriate ST. HELIER, Jersey – Novocure (NASDAQ: NVCR) announced today that the National … Continued
July 13, 2016
Second generation Optune system is less than half the weight and size of first generation Optune system New system aims to make Optune therapy even easier for glioblastoma (GBM) patients … Continued
July 07, 2016
PLEASANTON, Calif.–(BUSINESS WIRE)–NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today announced the recent addition of several new insurance positive coverage decisions … Continued
July 05, 2016
ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc., a developer of innovative products for the treatment of cartilage damage and osteoarthritis, announced today that it received Premarket Approval (PMA) from the U.S. Food and … Continued